cathAlert

Company Overview

Snapshot

Founded in March 2023 by Asi Elad, cathAlert operates with 1–10 employees. The company has secured funding across one round from one investor, Sanara Ventures, and is currently in the Pre-Seed stage. cathAlert holds one patent, indicating its focus on proprietary technology in the medical field.

Business overview

cathAlert develops a real-time computational image analysis system for angiogram videos, leveraging modern AI, including classical computer vision and deep learning methodologies. The system integrates into existing operator screens to extract visual information and provide notifications. It is designed to identify dangerous situations during catheter procedures, offering real-time alerts to operators and technicians to prevent complications and life-threatening scenarios. The company operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Medical Decision Support, targeting healthcare providers with its B2B business model.

Company Intelligence Q&A

What is cathAlert's primary product?

cathAlert's primary product is a real-time alert system that uses computational image analysis of angiogram videos to identify dangerous situations during catheter procedures, providing immediate notifications to medical staff.

When was cathAlert founded?

cathAlert was founded in March 2023.

Who is the founder of cathAlert?

The founder of cathAlert is Asi Elad.

What type of technology does cathAlert utilize?

cathAlert utilizes both classical computer vision and deep learning methodologies, applying modern AI to analyze angiogram videos.

What is the business model of cathAlert?

cathAlert operates on a B2B business model, targeting healthcare providers with its medical decision support system.